EUVIMEDEUVIMED entdecken
Crossref

Virtual screening targeting the conserved domain of the IAV M2 protein reveals the potential broad-spectrum anti-IAV activity of ajmaline

Min Chen, Wenhuan Chen, Xinyi Jiang, Shaomei Liang, Yingqiao Qin, Jiayi Tang, Yifei Li, Qifan Wu, Xue Liang, Pengcheng Wei, Kunpeng Liu, Sulan Luo

Biochemical and Biophysical Research Communications · 2026

DOI: 10.1016/j.bbrc.2026.153643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Min Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China. Hauptthemen laut MEDLINE: Antiviral Agents, Viral Matrix Proteins, Influenza A virus. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Program key projects, Guangxi University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza A virus (IAV) evolves rapidly through antigenic variation, leading to drug resistance and pandemic potential. To circumvent mutational escape, we employed a drug repurposing strategy targeting the evolutionarily conserved transmembrane domain (TMD) of the IAV M2 protein. Here, we report the discovery of Ajmaline, an antiarrhythmic alkaloid, as a broad-spectrum anti-IAV agent identified via virtual screening. Molecular docking and 100-ns dynamics simulations revealed stable binding across multiple IAV subtypes (H1N1, H2N2, H5N1, H7N9). The Cellular Thermal Shift Assay (CETSA) confirmed direct binding to both wild-type and N31S mutant M2 proteins. Ajmaline exhibited potent antiviral activity through dual mechanisms: direct inhibition of viral replication and upregulation of interferon-related genes (IFNB1, ISG56) coupled with suppression of apoptosis (Bax downregulation). In vivo, Ajmaline (15 mg/kg) improved survival to 83%, reduced pulmonary viral load, and alleviated lung pathology in H1N1-infected mice. These findings identify Ajmaline as a repurposed broad-spectrum antiviral candidate capable of overcoming existing drug resistance, providing a proof-of-concept for conserved-domain-targeting strategies in antiviral drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsViral Matrix ProteinsInfluenza A virusAnimalsViroporin ProteinsHumansMolecular Docking SimulationMiceVirus ReplicationProtein DomainsDogsMice, Inbred BALB CConserved SequenceOrthomyxoviridae InfectionsDrug Evaluation, Preclinical

Stichwörter der Autor:innen

AjmalineEvolutionarily conserved regionIAV-M2 proteinInfluenza A virusVirtual screening

Substanzen

Antiviral AgentsViral Matrix ProteinsViroporin ProteinsM2 protein, Influenza A virus

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
  • Institute of Digestive Disease, Guangxi Academy of Medical Sciences, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China. Electronic address: weipengcheng@gxu.edu.cn.
  • Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China. Electronic address: liukp@gxu.edu.cn.
  • Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China. Electronic address: sulan2021@gxu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Program key projects
  • Guangxi University of Science and Technology

Zitieren

APA

Chen, M., Chen, W., Jiang, X., Liang, S., Qin, Y., Tang, J., Li, Y., Wu, Q., Liang, X., Wei, P., Liu, K., & Luo, S. (2026). Virtual screening targeting the conserved domain of the IAV M2 protein reveals the potential broad-spectrum anti-IAV activity of ajmaline. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2026.153643

Vancouver

Chen M, Chen W, Jiang X, Liang S, Qin Y, Tang J, et al. Virtual screening targeting the conserved domain of the IAV M2 protein reveals the potential broad-spectrum anti-IAV activity of ajmaline. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2026.153643

BibTeX
@article{Chen2026,
  author = {Chen, Min and Chen, Wenhuan and Jiang, Xinyi and Liang, Shaomei and Qin, Yingqiao and Tang, Jiayi and Li, Yifei and Wu, Qifan and Liang, Xue and Wei, Pengcheng and Liu, Kunpeng and Luo, Sulan},
  title = {Virtual screening targeting the conserved domain of the IAV M2 protein reveals the potential broad-spectrum anti-IAV activity of ajmaline},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  doi = {10.1016/j.bbrc.2026.153643}
}
Kostenlos starten →